Biofrontera (BFRI) Cash from Investing Activities (2021 - 2025)
Biofrontera (BFRI) posted quarterly Cash from Investing Activities of $3.0 million for Q4 2025, up 300200.0% year-over-year from N/an in Q4 2024, and up 300000.0% quarter-over-quarter from $1000.0 in Q3 2025.
Biofrontera (BFRI) Cash from Investing Activities (2021 - 2025) Analysis & Trends
Biofrontera's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $3.0 million for Q4 2025.
- In Q4 2025, Cash from Investing Activities rose 300200.0% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (up 560.35% YoY), while the FY2025 annual figure was $3.0 million, up 100033.33% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at $3.0 million, up from $1000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $3.0 million in Q4 2025, with the low at -$3.0 million in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$1000.0 (2024), against an average of -$103200.0.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities slumped 303500.0% in 2022, then soared 300200.0% in 2025.
- Biofrontera's Cash from Investing Activities stood at -$9000.0 in 2021, then tumbled by 23077.78% to -$2.1 million in 2022, then surged by 103.5% to $73000.0 in 2023, then plunged by 101.37% to -$1000.0 in 2024, then jumped by 300200.0% to $3.0 million in 2025.
- Business Quant data shows BFRI's Cash from Investing Activities at $3.0 million in Q4 2025, $1000.0 in Q3 2025, and -$1000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Biofrontera | 19.06 Mn | 14.35 Mn | 9.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 1,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Sep 30, 2023 | 382,000.00 |
| Sep 30, 2023 | 382,000.00 |
| Jun 30, 2023 | 178,000.00 |
| Jun 30, 2023 | 178,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -2.09 Mn |
| Dec 31, 2022 | -2.09 Mn |